PTC Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to PTC Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update

PTC Therapeutics (PTCT) Tops Q2 EPS by 13c; Offers FY16 Outlook

August 4, 2016 5:10 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($1.14), $0.13 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $15.6 million versus the consensus estimate of $14.68 million.

2016 Guidance:

Total ex-U.S. Translarna nmDMD revenues for 2016 are anticipated to... More